Correlation Between Nuvectis Pharma and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Vaxcyte, you can compare the effects of market volatilities on Nuvectis Pharma and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Vaxcyte.

Diversification Opportunities for Nuvectis Pharma and Vaxcyte

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Nuvectis and Vaxcyte is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Vaxcyte go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Vaxcyte

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.83 times more return on investment than Vaxcyte. However, Nuvectis Pharma is 1.83 times more volatile than Vaxcyte. It trades about 0.03 of its potential returns per unit of risk. Vaxcyte is currently generating about 0.06 per unit of risk. If you would invest  740.00  in Nuvectis Pharma on November 9, 2024 and sell it today you would lose (16.00) from holding Nuvectis Pharma or give up 2.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Vaxcyte

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Vaxcyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nuvectis Pharma and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Vaxcyte

The main advantage of trading using opposite Nuvectis Pharma and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind Nuvectis Pharma and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.